Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
riferminogen pecaplasmid (NV1FGF, XRP0038)
Also known as: Temusi
print preview
bookmark
share with colleague
General Information
Company
Sanofi
Description
Non-viral DNA plasmid encoding fibroblast growth factor-1 (FGF-1)
Molecular Target
Fibroblast growth factor 1 (FGF1)
Mechanism of Action
Gene therapy
Latest Stage of Development
Phase III
Indication
Ischemia / reperfusion injury
Partner
Vical Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy